Irene Ghobrial is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Ghobrial has been practicing medicine for over 28 years and is rated as an Elite expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 15 other conditions, according to our data. Her top areas of expertise are Waldenstrom Macroglobulinemia, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, and Bone Marrow Transplant. She is licensed to treat patients in Massachusetts. Ghobrial is currently accepting new patients.
Neha Korde is an Oncologist and a Hematologist in Montvale, New Jersey. Korde has been practicing medicine for over 18 years and is rated as an Elite expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 13 other conditions, according to our data. Her top areas of expertise are Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Schnitzler Syndrome, and Bone Marrow Transplant. She is licensed to treat patients in New York. Korde is currently accepting new patients.
Sigurdur Kristinsson practices in Reykjavík, Iceland. Kristinsson is rated as an Elite expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). They are also highly rated in 14 other conditions, according to our data. Their top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant.
Summary: The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substa...
Summary: The primary purpose of this protocol is to create a registry of patients with plasma cell disorders (PCDs), including for example the cancer multiple myeloma (MM), who complete the assessment, previously known as a geriatric assessment, as is outlined in this protocol. Secondary objectives include measuring the response rate to participation of patients in this study, assessing patient satisfactio...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center